1. Home
  2. Drug interactions with cannabinoids

Drug interactions with cannabinoids

Author/s: 
Antoniou, T, Bodkin, J, Ho, JMW
Date Added: 
March 2, 2020
Journal/Publication: 
CMAJ: Canadian Medical Association Journal = journal de l'Association medicale canadienne
Publisher: 
Joule Inc.
Publication Date: 
March 2, 2020
Issue: 
9
Volume: 
192
Pages: 
E206
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
Keywords 
cannabinoids
drug interaction
cannabidiol
MeSH 
Humans
cannabis
Dronabinol
cannabidiol
CYP1A2 protein
Human
Cytochrome P-450 CYP1A2
cannabinoids
Cytochrome P-450 CYP3A Inhibitors
Analgesics
opioid
Ketoconazole
warfarin
Clozapine
Clobazam
CYP3A4 protein
Cytochrome P-450 CYP3A
Tacrolimus
Trimethoprim
Sulfamethoxazole Drug Combination
Sympathomimetics
Theophylline
Olanzapine
fluoxetine
Cytochrome P-450 CYP2C9
Cytochrome P-450 CYP2C9 Inhibitors
CYP2C19 protein
Cytochrome P-450 CYP2C19
Benzodiazepines
International Normalized Ratio
Marijuana Use
cholinergic antagonists
Verapamil
macrolides
Amiodarone
smoke
Sleepiness
Marijuana Smoking
Ataxia
Tobacco Products
Tachycardia
hypertension
liver
Transaminases

RPR Commentary

A nice one-page review of drug interactions with cannabinoids.  James W. Mold, MD, MPH

Abstract

No abstract available

Text Availability

Free full text